Suppr超能文献

[疫苗测试。测试复杂联合疫苗的挑战]

[Testing of vaccines. The challenge of testing complex combination vaccines].

作者信息

Merkle A, Lechner H, Oppling V, Meyer H

机构信息

Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, Paul-Ehrlich-Straße 51-59, 63225, Langen, Deutschland.

出版信息

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1188-92. doi: 10.1007/s00103-014-2037-x.

Abstract

Vaccines are biologicals. This group of medicinal products is produced with a predefined variability based on the biological starting materials used. Vaccines are subject to official control authority batch release performed by the Paul-Ehrlich-Institut (PEI). To release batches to the market, experimental testing has to be conducted by an official medicines control laboratory as the PEI. It is the aim of this independent testing to demonstrate the conformity of quality criteria with conditions set in the marketing authorization for each lot produced. The testing is performed on the basis of vaccine specific batch release guideline and due to the difficult and time consuming testing procedures often run in parallel with manufacturers testing. If test results comply with the predefined criteria, the lot in question is released. This article describes the challenge of official control authority batch release testing of two complex combination vaccines.

摘要

疫苗属于生物制品。这类药品是基于所使用的生物起始原料,以预先确定的变异性生产出来的。疫苗需由保罗·埃利希研究所(PEI)进行官方控制机构的批签发。为将批次投放市场,必须由作为PEI的官方药品控制实验室进行实验检测。这种独立检测的目的是证明每个生产批次的质量标准符合上市许可中规定的条件。检测是根据疫苗特定的批签发指南进行的,并且由于检测程序困难且耗时,通常与制造商的检测并行开展。如果检测结果符合预定标准,则相关批次予以放行。本文描述了两种复杂联合疫苗的官方控制机构批签发检测所面临的挑战。

相似文献

1
[Testing of vaccines. The challenge of testing complex combination vaccines].[疫苗测试。测试复杂联合疫苗的挑战]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1188-92. doi: 10.1007/s00103-014-2037-x.
2
[Testing of medicinal products produced from pooled plasma].[对混合血浆制备的药品进行的检测]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1181-4. doi: 10.1007/s00103-014-2035-z.
3
[Batch release of immunoglobulin and monoclonal antibody products].免疫球蛋白和单克隆抗体产品的批签发
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1185-7. doi: 10.1007/s00103-014-2034-0.
4
[Official testing of immunological veterinary medicinal products].[免疫兽用药品的官方检测]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1193-7. doi: 10.1007/s00103-014-2036-y.
6
[The network of official medicines control laboratories].[官方药品控制实验室网络]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1139-44. doi: 10.1007/s00103-014-2025-1.
7
Official batch control of influenza vaccines: Is it still useful?官方流感疫苗批次控制:它还有用吗?
Vaccine. 2018 Apr 19;36(17):2364-2370. doi: 10.1016/j.vaccine.2018.02.078. Epub 2018 Mar 23.
8
[Viral safety of biological medicinal products].[生物制品的病毒安全性]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1198-202. doi: 10.1007/s00103-014-2030-4.
9
Concept of biosimilar products in Jordan.约旦生物类似药产品的概念。
Biologicals. 2011 Sep;39(5):333-5. doi: 10.1016/j.biologicals.2011.06.013. Epub 2011 Aug 27.
10
[Experimental testing of centrally authorised medicinal products. The CAP programme].[中央授权药品的实验性测试。CAP 计划]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1169-72. doi: 10.1007/s00103-014-2031-3.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验